Shuttle Pharmaceuticals Holdings, Inc.
SHPH
$3.44
$0.05881.74%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 109.46% | 74.19% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 32.50% | 66.07% | |||
| Operating Income | -32.50% | -66.07% | |||
| Income Before Tax | -21.41% | -90.99% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -21.41% | -90.99% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -21.41% | -90.99% | |||
| EBIT | -32.50% | -66.07% | |||
| EBITDA | -32.55% | -66.18% | |||
| EPS Basic | 56.66% | 6.63% | |||
| Normalized Basic EPS | 56.66% | 6.63% | |||
| EPS Diluted | 56.66% | 24.09% | |||
| Normalized Diluted EPS | 56.66% | 6.63% | |||
| Average Basic Shares Outstanding | 180.12% | 104.58% | |||
| Average Diluted Shares Outstanding | 180.12% | 104.58% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||